The PEERLESS Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 692 participants.
Also called NCT05111613
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 692 participants
- Sponsor
- Registry
-
NCT05111613
-
- Main results
- Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial
- Other papers using this trial's data
- Evaluation of Catheter-Directed Thrombolysis Device Type and Dosing on Treatment Outcomes in Intermediate-Risk Pulmonary Embolism: A PEERLESS Randomized Controlled Trial Post Hoc Analysis
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT05111613. Randomized; no masking; primary purpose treatment. Start 2022-02-14 (actual); primary completion 2024-03-01 (actual). Results posted on 2025-11-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The PEERLESS Study
- Acronym
- PEERLESS
- Condition
- Pulmonary Embolism
- Condition
- Pulmonary Thromboembolism
- Intervention (Device)
- Catheter-Directed Thrombolysis
- Intervention (Device)
- FlowTriever System
- Lead sponsor
- Inari Medical
Record details
- Record id
cardio:ct-nct05111613- Content hash
ab8c6c38c34a9a37054f50eabaab5817f4c2c7854d80011cae72adc170a35c36